Multiple Myeloma in Combination with Dexamethasone in Adult Patients with Relapsed and Refractory Disease Who Have Received At Least Two Prior Treatment Regimens Including Both Lenalidomide and Bortezomib and Have Demonstrated Disease Progression on The Last Therapy

The medicines shown here belong to the Oncology Support category and are used for managing Multiple Myeloma in Combination with Dexamethasone in Adult Patients with Relapsed and Refractory Disease Who Have Received At Least Two Prior Treatment Regimens Including Both Lenalidomide and Bortezomib and Have Demonstrated Disease Progression on The Last Therapy. Products containing Pomalidomide feature in this group.